✦ LIBER ✦

Serum sialic acid changes in type 2 diabetic patients on metformin or rosiglitazone treatment

✍ Scribed by I. U. Rahman; S. A. Malik; M. Bashir; R. U. Khan; M. Idrees

Book ID: 108849342
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 78 KB
Volume: 35
Category: Article
ISSN: 0269-4727
DOI: 10.1111/j.1365-2710.2009.01145.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metformin-glibenclamide versus metformin

Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy

✍ A. Garber; E. Klein; S. Bruce; S. Sankoh; P. Mohideen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Initial treatment with rosiglitazone/met

Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes

✍ J. Rosenstock; J. Rood; A. Cobitz; N. Biswas; H. Chou; A. Garber 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

Serum sialic acid in South Indian Type 2

Serum sialic acid in South Indian Type 2 diabetic patients with microvascular complications

✍ Vijay, V.; Snehalatha, C.; Ramachandran, A.; Jayaraman, M. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 25 KB 👁 1 views

## LETTER mmol l -1 , p = 0.012) in comparison with predictor of diabetic complications is limited. normal controls (2.31 ± 0.32 mmol l -1 ). LETTER Sialic acid values were higher than the healthy controls in the 38 normoalbumin-V. Vijay, C. Snehalatha, A. Ramachanduric, 33 microalbuminuric, and 3

Response to Pokharna and Kanna: Initial

Response to Pokharna and Kanna: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes

✍ A. Garber 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB

Acute myopathy in a type 2 diabetic pati

Acute myopathy in a type 2 diabetic patient on combination therapy with metformin, fenofibrate and rosiglitazone

✍ M. Ledl; J. Hohenecker; C. Francesconi; I. Roots; M. F. Bauer; M. Roden 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 87 KB

Serum sialic acid in subjects with impai

Serum sialic acid in subjects with impaired glucose tolerance and in newly diagnosed type 2 diabetic patients

✍ M. Gavella; V. Lipovac; A. Car; M. Vučić; L. Sokolić; R. Rakoš 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 70 KB